FDA Inspection 1274601 — Nippon Protein Co., Ltd. Ashikaga Plant
The FDA completed an inspection of Nippon Protein Co., Ltd. Ashikaga Plant on June 27, 2025 in Ashikaga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 27, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ashikaga (Japan)